Hebei, China

Chunlei Li

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Shijiazhuang, CN (2018 - 2019)
  • Hebei, CN (2014 - 2023)

Company Filing History:


Years Active: 2014-2023

where 'Filed Patents' based on already Granted Patents

5 patents (USPTO):

Title: Discovering the Innovative Mind of Chunlei Li

Introduction

Chunlei Li, hailing from Hebei, China, is a prominent inventor with a remarkable portfolio of five patents. Renowned for his contributions to pharmaceutical technology, Li's work primarily focuses on novel treatments for various forms of lymphoma, particularly non-Hodgkin's lymphoma. His innovative approach has significantly advanced the field of targeted cancer therapies.

Latest Patents

Li's most recent patent, "Use of mitoxantrone liposome for treating non-Hodgkin's lymphoma," introduces a groundbreaking liposomal pharmaceutical preparation of mitoxantrone specifically designed to treat aggressive forms of non-Hodgkin's lymphoma, including relapsed or refractory cases. Notably, this patent emphasizes the use of mitoxantrone liposomes as a standalone therapeutic agent, highlighting their potential effectiveness without the necessity for combination with other treatments.

Another significant patent by Li involves a liposome featuring a bilayer and an inner water phase, which contains sulfobutyl ether cyclodextrin as well as an active compound. This innovation presents exciting possibilities for enhancing drug delivery and efficacy in therapeutic applications.

Career Highlights

Chunlei Li is currently affiliated with Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a commitment to developing more effective cancer treatments and improving patient outcomes.

Collaborations

Li has collaborated with notable colleagues such as Caixia Wang and Yanhui Li. Together, they contribute their expertise to the ongoing research and development within the pharmaceutical field, reinforcing the significance of teamwork in driving innovation.

Conclusion

Chunlei Li stands out as a significant figure in the realm of pharmaceutical inventions. His dedication to improving cancer treatment through innovative methodologies demonstrates his invaluable contribution to medical science. As he continues his work at Cspc Zhongqi Pharmaceutical Technology, the future holds great potential for further groundbreaking developments from this talented inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…